We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Entering the era of phage therapy: A 'happy hour' for inflammatory bowel diseases.
- Authors
Pessina, Benedetta; Guarnieri, Valentina; Scarallo, Luca
- Abstract
In addition, a 5-phage subset was shown to reduce the bacterial burden of two IBD-associated Kp2 strains in a monocolonized colitis mouse model without evidence of anti-phage resistance development (Figure 1(4)). Entering the era of phage therapy: A "happy hour" for inflammatory bowel diseases Keywords: animal models; basic immunology; inflammation; microbiome; virus EN animal models basic immunology inflammation microbiome virus 889 891 3 03/08/23 20230301 NES 230301 Inflammatory bowel disease (IBD) is a global disease[1] with a multifactorial aetiology, including an interaction between genetic and environmental factors.[2] Some gut pathobionts may contribute to uncontrolled intestinal inflammation in genetically susceptible individuals.
- Subjects
INFLAMMATORY bowel diseases; BACTERIOPHAGES; HAPPY hours; MULTIDRUG resistance in bacteria; GREEN fluorescent protein
- Publication
Allergy, 2023, Vol 78, Issue 3, p889
- ISSN
0105-4538
- Publication type
Article
- DOI
10.1111/all.15636